Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Moberg Pharma's Fungal Nail Product Approved in China

publication date: Jan 27, 2015
Moberg Pharma AB of Sweden said its partner, Menarini Asia-Pacific, received China approval to market Kerasal Nail™, an OTC fungal nail product. Kerasal Nail treats nails that are discolored/deformed from fungal infection or psoriasis. First approved in Sweden in 2011, Kerasal is now available in more than 25 countries. Menarini distributes the product in Italy, and in 2013, its Menarini Asia-Pacific division became Kerasal Nail's distributor for China and eight APAC countries. More details....

Stock Symbol: (OMX: MOB)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here